Lataa...
PEDT-05 USEFULNESS OF BEVACIZUMAB IN MAINTAINING QOL AT DIPG RELAPSE
INTRODUCTION: Even in the age of molecular diagnosis, diffuse intrinsic pontine glioma (DIPG) is still a dismal disease, and there is no effective treatment. The usefulness of bevacizumab for DIPG relapse is reported. SUBJECTS AND METHODS: The treatment and outcomes of 10 patients with DIPG who were...
Tallennettuna:
| Julkaisussa: | Neurooncol Adv |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7213212/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz039.073 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|